Westport Advisers’s Charles River Laboratories CRL Stock Holding History

Westport Advisers’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	$12.4M	Sell	150,000 -5,000	-3%	-$412K	2.28%	17
2016 Q1	$11.8M	Hold	155,000	–	–	1.84%	22
2015 Q4	$12.5M	Hold	155,000	–	–	1.8%	22
2015 Q3	$9.85M	Hold	155,000	–	–	1.33%	27
2015 Q2	$10.9M	Hold	155,000	–	–	1.19%	30
2015 Q1	$12.3M	Hold	155,000	–	–	1.28%	29
2014 Q4	$9.86M	Hold	155,000	–	–	1.01%	35
2014 Q3	$9.26M	Hold	155,000	–	–	0.92%	40
2014 Q2	$8.3M	Hold	155,000	–	–	0.79%	41
2014 Q1	$9.35M	Hold	155,000	–	–	0.89%	40
2013 Q4	$8.22M	Hold	155,000	–	–	0.74%	43
2013 Q3	$7.17M	Hold	155,000	–	–	0.66%	47
2013 Q2	$6.36M	Buy	+155,000	New	+$6.64M	0.62%	52

Other funds holding CRL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Westport Advisers's CRL Position: Q2 2016 in Review

Westport Advisers reduced its Charles River Laboratories (CRL) stake by 3.2% in Q2 2016, selling an estimated $412K and leaving 150,000 shares worth $12.4M. The position accounts for 2.28% of the portfolio, ranked #17.

Westport Advisers first reported a position in CRL in Q2 2013 and has held it in 13 quarters since. The position peaked at $12.5M in Q4 2015. 286 funds tracked by Wall St. Rank hold CRL as of Q2 2016.

Westport Advisers held 150,000 shares of Charles River Laboratories worth $12.4M as of Q2 2016.
Westport Advisers sold 5,000 Charles River Laboratories shares in Q2 2016, an estimated $412K.
Charles River Laboratories made up 2.28% of Westport Advisers's portfolio in Q2 2016, its #17 holding.
Westport Advisers first reported a position in Charles River Laboratories in Q2 2013 and has held it in 13 quarters since.
Westport Advisers's Charles River Laboratories position peaked at $12.5M in Q4 2015.
286 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2016.

Based on Westport Advisers's 13F filing for Q2 2016, filed 15 Aug 2016.